Only one in five U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a new study shows.
Only one in five U.S. pancreatic cancer patients get this key blood test at diagnosis
Ready to get ripped?
Introducing the BEST SELLING diet and training program to get you beach-ready for summer.
